Equillium (EQ) Current Deferred Revenue (2022 - 2024)

Equillium (EQ) has 3 years of Current Deferred Revenue data on file, last reported at $2.1 million in Q3 2024.

• On a quarterly basis, Current Deferred Revenue fell 86.94% year-over-year to $2.1 million in Q3 2024; TTM through Sep 2024 was $2.1 million, a 86.94% decrease from a year earlier, with the FY2023 full-year figure at $15.7 million, up 7.0% from the prior year.
• Current Deferred Revenue for Q3 2024 stood at $2.1 million, down from $8.4 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for EQ reached as high as $15.8 million in Q3 2023 and fell as low as $2.1 million in Q3 2024.
• Historically, Current Deferred Revenue has averaged $12.4 million across 3 years, with a median of $14.5 million in 2022.
• Across the five-year window, Current Deferred Revenue advanced 7.0% in 2023 and tumbled 86.94% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $14.7 million in 2022, then grew by 7.0% to $15.7 million in 2023, then tumbled by 86.85% to $2.1 million in 2024.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $2.1 million in Q3 2024, $8.4 million in Q2 2024, and $13.4 million in Q1 2024.